Showing 1-3 of 3 results
Children's Oncology Group Member
Funded: 07-01-2005 through 06-30-2017
Funding Type: Cooperative Research Grant (COG)
Institution Location: Bern, Switzerland
Institution: Swiss Paediatric Oncology Group - Bern

This institution is a member of the Children's Oncology Group (COG). From the first event in 2000 until 2004, St. Baldrick's funds benefited the COG. Since the St. Baldrick's Foundation began making grants in 2005, each of the 200 member institutions of the COG has received a portion of a multi-million dollar St. Baldrick's grant every year. These funds have been distributed based on the number of patients at each institution who are treated on COG clinical trials, their best hope for a cure.

Children's Oncology Group Member
Funded: 07-01-2005 through 06-30-2017
Funding Type: Cooperative Research Grant (COG)
Institution Location: Geneva, Switzerland
Institution: Swiss Paediatric Oncology Group - Geneva

This institution is a member of the Children's Oncology Group (COG). From the first event in 2000 until 2004, St. Baldrick's funds benefited the COG. Since the St. Baldrick's Foundation began making grants in 2005, each of the 200 member institutions of the COG has received a portion of a multi-million dollar St. Baldrick's grant every year. These funds have been distributed based on the number of patients at each institution who are treated on COG clinical trials, their best hope for a cure.

Children's Oncology Group Member
Funded: 07-01-2005 through 06-30-2017
Funding Type: Cooperative Research Grant (COG)
Institution Location: Lausanne, Switzerland
Institution: Swiss Paediatric Oncology Group - Lausanne

This institution is a member of the Children's Oncology Group (COG). From the first event in 2000 until 2004, St. Baldrick's funds benefited the COG. Since the St. Baldrick's Foundation began making grants in 2005, each of the 200 member institutions of the COG has received a portion of a multi-million dollar St. Baldrick's grant every year. These funds have been distributed based on the number of patients at each institution who are treated on COG clinical trials, their best hope for a cure.